Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
06/2000
06/29/2000WO1998050067A3 Use or a secretion vector for fertility control by oral vaccination
06/29/2000CA2356452A1 Compositions and methods for reducing or preventing fertilization in fish and birds
06/29/2000CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
06/29/2000CA2356181A1 Triazineone compounds for treating diseases due to sarcocystis, neospora and toxoplasma
06/29/2000CA2355861A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
06/29/2000CA2355368A1 Cgmp pde 5 inhibitors for inhalation in the treatment of sexual dysfunction
06/29/2000CA2355251A1 New .beta.-amide and .beta.-sulfonamide carboxylic acid derivatives, their preparation and their use as endothelin receptor antagonists
06/29/2000CA2355148A1 Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions
06/29/2000CA2355137A1 Non-peptide nk1 receptors antagonists
06/29/2000CA2353907A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
06/28/2000EP1013639A1 Aryl carboxylic acid and tetrazole derivatives comprising a carbamoyloxy unit
06/28/2000EP1013275A2 Method and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
06/28/2000EP1012273A2 Secreted proteins and polynucleotides encoding them
06/28/2000EP1012176A1 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens
06/28/2000EP1012154A2 Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof
06/28/2000EP1011721A1 Vaginal lactobacillus medicant
06/28/2000EP1011695A1 Use of neurotoxin therapy for treatment of urologic and related disorders
06/28/2000EP1011682A2 Hormonal contraceptive
06/28/2000EP1011681A1 Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin
06/28/2000EP1011667A1 Antagonists of gonadotropin releasing hormone
06/28/2000EP1011636A1 New foam-forming pharmaceutical composition
06/28/2000EP1011632A2 A pharmaceutical composition for treating dysmenorrhea and premature labor
06/28/2000CN1258286A Non-steroidal (hetero) cyclically substd. acylanilides with mixed gestagen and androgen activity
06/28/2000CN1257864A Imidazoline compound, preparing process thereof and pharmaceutical composition contg. same
06/28/2000CN1257728A Medical capsule for building up body and invigorating function of kidney
06/28/2000CN1053904C N-pyridyl carboxamides and derivs. processes for their preparation and pharmaceutical compositions contg. them
06/28/2000CN1053886C Naphthyl compounds, intermediates and their preparing method and use
06/28/2000CN1053833C Kidney-reinforcing Yang-strengthening powder
06/28/2000CN1053829C Method for preparation of Chinese medicine for gynecopathy
06/27/2000US6080841 Human induced tumor protein
06/27/2000US6080774 Substituted biphenylsulfonamide endothelin antagonists
06/27/2000US6080764 Superoxide radical inhibitor
06/27/2000US6080761 Inhibition of smooth muscle cell migration by (R)-amlodipine
06/27/2000US6080754 For treatment and prophylaxis of estrogen related syndromes and disorders
06/27/2000US6080735 Estra-1,3,5(10)-trien derivatives, processes for their preparation and pharmaceutical compositions containing these compounds
06/27/2000CA2198564C Method of reducing tissue damage associated with non-cardiac ischemia
06/23/2000CA2596416A1 Methods of extended use oral contraception
06/22/2000WO2000036104A1 Pancreatic polypeptide zsig66
06/22/2000WO2000035938A1 22s-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity
06/22/2000WO2000035919A2 Quinoline derivatives
06/22/2000WO2000035907A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
06/22/2000WO2000035892A1 Piperazine ethylamide derivatives with 5-ht1a receptor activity
06/22/2000WO2000035891A1 Morpholinone and morpholine derivatives and uses thereof
06/22/2000WO2000035878A1 1,4-piperazine derivatives having 5ht1a receptor activity
06/22/2000WO2000035875A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity
06/22/2000WO2000035465A2 Oral administration of lactobacillus for the treatment and prevention of urogenital infection
06/22/2000WO2000035463A1 Method for producing a material containing cells from the prostate gland, material containing cells from the prostate gland and methods for treating uterus fibromatosis, chronic prostatitis and disorders of the male sexual function according to a transplantation technique
06/22/2000WO2000035457A1 Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males
06/22/2000WO2000016632A3 Environmentally benign crop protection agents
06/22/2000WO2000012504A3 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one
06/22/2000WO1999054707A3 Fetal testing for prediction of low birth weight
06/22/2000WO1999038504A8 Pharmaceutical uses of optically pure (-)-bupropion
06/22/2000CA2440933A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
06/22/2000CA2355234A1 Quinoline derivatives
06/22/2000CA2355202A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
06/22/2000CA2355201A1 Morpholinone and morpholine derivatives and uses thereof
06/22/2000CA2355039A1 Pancreatic polypeptide zsig66
06/22/2000CA2354601A1 Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males
06/22/2000CA2352337A1 22s-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity
06/22/2000CA2351860A1 Piperazine ethylamide derivatives with 5-ht1a receptor activity
06/22/2000CA2351859A1 1,4-piperazine derivatives having 5ht1a receptor activity
06/22/2000CA2351400A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity
06/22/2000CA2290220A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
06/21/2000EP1010694A2 Spiroimidazoline derivatives and their use as alpha2-adrenergic antagonists and monoamines-reuptake blockers
06/21/2000EP1010693A1 Imidazoline derivatives, preparation and pharmaceutical compositions containing them
06/21/2000EP1010431A2 Botulinum toxins for treating pain associated with muscle spasms
06/21/2000EP1009762A2 Lipocalin homologs
06/21/2000EP1009737A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
06/21/2000EP1009730A1 New pentaerythritol derivatives, their production and use and intermediates for their synthesis
06/21/2000EP1009428A1 Vaginal suppository vaccine for urogenital infections
06/21/2000EP1009414A2 Novel pharmaceutical composition
06/21/2000EP1009384A1 A method of administering liposomal encapsulated taxane
06/21/2000DE19858779A1 New 3-acylamino-propionic acid and 3-sulfonylamino-propionic acid derivatives useful as endothelin receptor antagonists in treatment of e.g. cardiovascular and renal disorders, migraine and cancer
06/21/2000CN1257499A 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors
06/21/2000CN1256941A Traditional Chinese medicine for treating hydroperididymia and funicular hydrocele and preparation process thereof
06/21/2000CN1256917A Method for rasing sow conception, farrowing and surical rate by using vitamin E
06/21/2000CN1053672C Azasteroid compounds for treating prostatic hypertrophy, their preparation and use
06/21/2000CN1053585C Medicine for treating prostate diseases
06/20/2000US6077873 Steroid compounds having contraceptive and anti-osteoporosis activity
06/20/2000US6077841 For treating sexual disorders, male impotency, heart failure, pulmonary hypertension, and angina
06/20/2000CA2198536C Method of reducing tissue damage associated with ischemia
06/20/2000CA2198535C Method of increasing testosterone
06/20/2000CA2001618C Gestodene-containing agent for transdermal administration
06/20/2000CA1341029C Peptidase inhibitors
06/15/2000WO2000034498A1 Two-step immunization procedure against chlamydia infection
06/15/2000WO2000034481A2 DRUG TARGETS IN $i(CANDIDA ALBICANS)
06/15/2000WO2000034472A1 Spermatogenesis protein
06/15/2000WO2000034334A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
06/15/2000WO2000034248A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
06/15/2000WO2000034244A1 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
06/15/2000WO2000034228A1 Ion channel modulating agents
06/15/2000WO2000033845A1 Remedial agent for erectile dysfunction
06/15/2000WO2000033840A1 Use of acetylcholinesterase inhibitors on the modulation of the hypothalamic-pituitary-gonadal axis
06/15/2000WO2000033834A1 Use of isatin derivatives as ion channel activating agents
06/15/2000WO2000033828A1 Agent for lowering endothelin levels
06/15/2000WO2000033825A2 Compositions and methods for amelioration of human female sexual dysfunction
06/15/2000WO2000010536A8 Extended release buccal bioadhesive tablet
06/15/2000WO2000006531A3 Nitric esters and nitrate salts of specific drugs
06/15/2000CA2354035A1 Use of acetylcholinesterase inhibitors on the modulation of the hypothalamic-pituitary-gonadal axis
06/15/2000CA2353525A1 Drug targets in candida albicans